Why Marinus Pharmaceuticals Stock Skyrocketed 80% Higher Today
Shares of Marinus Pharmaceuticals (NASDAQ: MRNS) were skyrocketing higher on Tuesday morning, trading up by 80% as of 11:35 a.m. EDT. The huge jump came after the company announced positive results from a pivotal late-stage study evaluating its drug candidate ganaxolone in children and young adults with CDKL5 deficiency disorder (CDD), a rare type of epilepsy.
All of Marinus' chips have been riding on ganaxolone -- its sole pipeline candidate. That big bet now seems to have paid off.
Image source: Getty Images.
Source Fool.com
